Radiation therapy for advanced heart failure
Part of Heart & circulation clinical trials.
This study tests a new radiation treatment for advanced heart failure. It aims to see if radiation can improve heart function and symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have heart failure with a reduced pumping ability (ejection fraction of 40% or less).
- You have symptoms of heart failure (NYHA class II or III).
- You have been hospitalized for heart failure in the last 6 months or have a high level of a heart stress marker (NT-pro BNP).
- You are not eligible for a heart transplant or a mechanical heart pump.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether very low doses of radiation can help people with chronic heart failure whose symptoms persist despite standard treatments. It aims to reduce inflammation in the heart and improve how well it pumps.
This trial tests if a low dose of radiation to the heart can help people with advanced heart failure feel better and improve heart function. It is for patients whose heart failure is stable but severe, and who are already on the best medications.
This trial tests if a low dose of radiation to the whole heart can help people with very advanced heart failure. It is for people who have severe symptoms despite maximum medications and are not candidates for a heart pump or transplant.
This trial tests a new way to plan radiation for cancers in the chest area (like lung, esophageal, or thymus cancers) that aims to protect the heart from high doses of radiation. It is for people who need daily radiation for at least three weeks and who are expected to live more than a year.
This trial looks at how radiation for lung, esophageal, or breast cancer affects the heart. It may help doctors reduce heart damage in future patients.
This trial tests an early heart-focused intervention guided by a special heart recording (impedance cardiography) in people with locally advanced, unresectable stage III non-small cell lung cancer. The goal is to improve heart-related safety during planned radiation and chemotherapy, with or without immunotherapy.
Hear when a new Advanced or End-stage Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.